A Knowledge Test and ACCU-CHEK Inform II System Skills Checklist have also been added to document proficiency and certification in blood glucose monitoring with the ACCU-CHEK Inform II system. © American Association for Clinical Chemistry 2021. The multiple-patient use Accu-Chek Inform II Blood Glucose Monitoring System will consist of: Meter: Accu-Chek Inform II Meter Test Strip. Accu-Chek Inform II Systems by Roche Diagnostics BID13509001CS. The following information will assist you in developing an ACCU-CHEK Inform II system in-service program for your institution. The ACCU-CHEK Inform II system demonstrated clinically acceptable performance against the PCA-HK reference method for blood glucose monitoring in a diverse population of critically ill patients in US care settings.īlood glucose blood glucose monitoring blood sugar in intensive care unit critical care laboratory performance evaluation point of care testing. Clinical evaluation demonstrated high specificity and sensitivity, with low risk of potential insulin-dosing errors. Use strips at temperatures between 16☌ and 35☌ (61☏ - 95☏) and between 10-80 relative humidity. Store between 5☌ and 40☌ and 10-85 humidity. Proportions of results within evaluation boundaries 1 and 2, respectively, were 96% and 98% for venous samples, 94% and 97% for pediatric and adult arterial samples, 84% and 98% for neonatal arterial samples, and 96% and 100% for neonatal heel-stick samples. Accu-Chek Inform II meter, base and power supply: a. Please be sure to read the policy for the facility where you will be completing your clinicals. Clinical performance was assessed by evaluating sample data using Parkes error grid, Monte Carlo simulation, and sensitivity and specificity analyses to estimate clinical accuracy and implications for insulin dosing when using the ACCU-CHEK Inform II system. This module contains the ACCU-CHEK INFORM II policy for VVMC and FMC. The ACCU-CHEK Inform II system was evaluated at 2 cutoff boundaries: boundary 1 was ≥95% of results within ☑2 mg/dL of the reference (samples with blood glucose <75 mg/dL) or ☑2% of the reference (glucose ≥75 mg/dL), and boundary 2 was ≥98% of results within ☑5 mg/dL or ☑5% of the reference. Overall, 476 arterial (376 pediatric/adult, 100 neonate), 375 venous, and 100 neonatal heel-stick whole-blood samples were collected and evaluated from critical care settings at 10 US hospitals, including the emergency department, medical and surgical intensive care units (ICUs), and neonatal and pediatric ICUs. The Accu-Chek Inform II will automatically store a record of patient and quality control glucose results and will transfer data. Our purpose was to evaluate the performance of the ACCU-CHEK® Inform II blood glucose monitoring system (Roche Diagnostics GmbH) compared with the perchloric acid hexokinase (PCA-HK) comparator method on the cobas® 6000 analyzer (Roche Diagnostics International Ltd) in critically ill patients. The Roche Accu-Chek Inform ll system is intended for in vitro diagnostic use in the quantitative determination of blood glucose levels in venous, capillary, arterial and neonatal whole blood.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |